Article
Genetic screening for the predisposition to venous thromboembolism: a cost-utility analysis of clinical practice in the Italian health care system.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research - 1 Jan 2000
Compagni Amelia, Melegaro Alessia, Tarricone Rosanna
Abstract excerpt
OBJECTIVES: In the Italian health care system, genetic tests for factor V Leiden and factor II are routinely prescribed to assess the predisposition to venous thromboembolism (VTE) of women who request oral contraception. With specific reference to two subpopulations of women already at risk (i.e., familial history or previous event of VTE), the study aimed to assess whether current screening practices in Italy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
